Introduction
The introduction of transvaginal ultrasound in routine gynecological practice has increased the number of asymptomatic lesions identified in postmenopausal women (1Á4). The prevalence of endometrial polyps is unknown because they frequently occur without associated symptomatology, but in women with abnormal bleeding, it has been reported to range from 13% to 50% (3) . Even though most lesions are benign, some are premalignant (simple or complex hyperplasia with cytological atypia) or malignant (endometrial cancer) (2) . Although the malignancy potential of endometrial polyps is uncertain, they are believed to be a risk factor for endometrial cancer and the actual incidence of malignancy detected in endometrial polyps has ranged between 0.5% and 4.8% (1, 4) . The entire suspicious lesion can be removed under direct vision by hysteroscopic polypectomy, which is generally regarded as the 'gold standard' for the diagnosis of polyps (2,4) and recommended for symptomatic patients. A similar approach is reasonable for asymptomatic polyps in postmenopausal women to disprove a malignant condition, although this procedure is arguable (1, 3, 4) .
The objective of this study was to evaluate the risk of malignancy of endometrial polyps in postmenopausal women according to the presence or absence of symptomatology.
Material and methods
From the Departmental hysteroscopy database, we selected all 481 postmenopausal women who underwent a diagnostic hysteroscopy between 2004 and 2007 and were diagnosed with endometrial polyps. We considered postmenopausal women older than 40 years who had cessation of menstrual period more than 12 months before, and abnormal uterine bleeding was considered to be any uterine bleeding thereafter.
All patients were referred for diagnostic hysteroscopy because of abnormal uterine bleeding or an abnormal transvaginal ultrasound finding. The women were considered in two groups: those with episodes of postmenopausal bleeding and those asymptomatic. From the medical records, data were collected on age, menopausal age, use of hormonal therapy, and medical conditions associated with endometrial cancer risk (hypertension, diabetes). Transvaginal ultrasound findings before hysteroscopy were evaluated for both groups.
Operative hysteroscopy was proposed to all patients, usually as an ambulatory procedure; but when not possible/tolerated/accepted by the patient, a surgical hysteroscopy was done under general anesthesia, using a 9 mM Storz resectoscope. The identified lesion was completely removed. Histological results in both groups were compared.
The data were analyzed using SPSS version 15.0, with chi-squared test for qualitative and the t-test for quantitative variables. A value of pB0.05 was considered significant. Logistic regression analysis was used to determine adjusted odds ratios and 95% confidence intervals of abnormal uterine bleeding, hormonal therapy use, hypertension, and diabetes on tumor incidence. Table I . Diagnosed polyps were surgically removed in, respectively, 74.5% vs. 73.6% of the women. In the remaining cases, removal was either performed outside our department or refused by the patients.
Results

Of
The histopathologic results of the removed polyps (Table I ) revealed mucous polyps in 93.7% of the asymptomatic women and 80.7% of those bleeding. Endometrial tumor material was only noted in the symptomatic group (7.2%; p B0.0001), and cytological atypia was also more frequent in this group (2.2%, p 00.021). Logistic regression analysis showed a significant increase (pB0.0001) in the incidence of malignancy in the polyps of women who presented with abnormal uterine bleeding (when compared to asymptomatic group), but no significant influence of hormone replacement therapy (HRT) (p 00.247; OR 0.34, 95% CI: 0.04Á2.65), hypertension (p 00.367; OR 1.37, 95% CI: 0.49Á 3.86) or diabetes (p 00.414; OR 1.54, 95% CI: 0.33Á7.13). For the incidence of pre-malignancy in polyps, analysis also showed significant influence of postmenopausal bleeding (p00.021; OR 8.05, 95% CI: 0.99Á65.02), but no significant influence of HRT (p 00.535; OR 0.61, 95% CI: 0.08Á4.97), 
Discussion
The rate of malignancy in endometrial polyps, i.e. 13 cases or 2.7% of the total study population, was within the range reported of 0.8Á4.8% (3Á6).
Although uterine bleeding as a predictive factor for malignancy in endometrial polyps has not been universally reported (4) , and risk of pre-malignancy and malignancy within endometrial polyps in postmenopausal women differed, in our study similar to others the risk was significantly higher in the symptomatic group with the presence of vaginal bleeding (3, 5, 7) . We also observed that the risk of a pre-malignant or malignant lesion in a polyp was not affected by use of HRT or by the presence of others risks factors for malignancy, such as hypertension or diabetes, consistent with other authors (4, 5) . Considering this, operative hysteroscopy with complete removal of the polyp (a safe procedure in this age group) should be offered to all symptomatic patients, regardless of the presence or absence of risk factors (1, 2, 5) .
The evaluation of polyps in asymptomatic women may allow the detection of pre-malignant conditions and an earlier diagnosis of endometrial carcinoma (1) . The presence of malignancy in extracted polyps of this group of women was reported in one large study, but it included a heterogeneous population of pre-and postmenopausal patients (1, 5) . A decision to remove asymptomatic polyps in postmenopausal women must take into consideration certain factors like the inherent risk of malignancy or pre-malignant pathology, the potential malignant transformation of benign incidental polyps over the years if left in situ and the risks of the procedure itself (1).
In women with a high operative risk, conservative management may be a safe option (1,2,4) . The results of this study suggest that in asymptomatic postmenopausal women with endometrial polyps confirmed by hysteroscopy, in whom ambulatory or programmed operative hysteroscopy is not possible, transvaginal ultrasound or diagnostic hysteroscopy in a regular surveillance scheme are alternative options to surgery, being a safe procedure and reducing surgical morbidity.
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